Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in
Advertisement

Market-Moving News for March 9th

Benzinga Newsdesk 7 months ago

MoversTrading Ideas

HIMS: 54% | Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report   RLMD: 80% | Relmada Therapeutics Announces 12-month Interim Data From Its

HIMS: 54% | Novo Nordisk And Hims & Hers End Bitter Legal Feud With Surprise Weight-Loss Drug Deal: Report

 

RLMD: 80% | Relmada Therapeutics Announces 12-month Interim Data From Its Ongoing Phase 2 Trial Of NDV-01 For High-risk Non-muscle Invasive Bladder Cancer

 

 

 

 

Read the original

Advertisement